1981
DOI: 10.4269/ajtmh.1981.30.942
|View full text |Cite
|
Sign up to set email alerts
|

Immunoenzymatic Assay (Elisa) in Mucocutaneous Leishmaniasis, Kala-Azar, and Chagas' Disease: An Epimastigote Trypanosoma cruzi Antigen Able to Distinguish between Anti-Trypanosoma and Anti-Leishmania Antibodies *

Abstract: Areas where mucocutaneous leishmaniasis, kala-azar and Chagas' disease are prevalent often overlap in Latin America. Due to a variable degree of cross-reactivity between the three etiological agents and antibodies synthesized during the course of the disease, a test able to distinguish between them is greatly needed. Saline-extracted antigen from live Trypanosoma cruzi epimastigotes behaved towards Chagas' disease sera in immunoenzymatic assays (ELISA) with the same specificity and sensitivity as the antigen u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
17
0
1

Year Published

1987
1987
2007
2007

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 41 publications
(21 citation statements)
references
References 0 publications
3
17
0
1
Order By: Relevance
“…Thus, the rORFF-based ELISA appears more sensitive than the DAT, which is known for a high degree of specificity and sensitivity for VL. 7,16 The slightly elevated OD 405 values for noninfected individuals from endemic regions compared with those from non-endemic regions may reflect subclinical infection. 24 Since the assay has not yet been fully optimized with respect to antigen amount and serum dilution, it is conceivable that an assay can be developed that will accurately predict the parasitologic status of all VL patients.…”
Section: Resultsmentioning
confidence: 99%
“…Thus, the rORFF-based ELISA appears more sensitive than the DAT, which is known for a high degree of specificity and sensitivity for VL. 7,16 The slightly elevated OD 405 values for noninfected individuals from endemic regions compared with those from non-endemic regions may reflect subclinical infection. 24 Since the assay has not yet been fully optimized with respect to antigen amount and serum dilution, it is conceivable that an assay can be developed that will accurately predict the parasitologic status of all VL patients.…”
Section: Resultsmentioning
confidence: 99%
“…The pellets were resuspended in 200 volumes of 0.15 M NaOH containing 0.014 M PMSF (Sigma) followed by three cycles of sonication at 40 Hz for 20 s each time in an ice bath [11]. The suspension was slowly shaken (150 rpm) for 6 h at 4 o C. The pH was adjusted to 7.2, and the material kept under slow shaking overnight.…”
Section: Parasite and Antigensmentioning
confidence: 99%
“…Among the serological tests used for the diagnosis are the direct agglutination, indirect immunofluorescence (IIF), and enzyme immunoassay (EIA). Some EIA techniques for the ACL diagnosis were described by several authors that used L. braziliensis [11][12][13][14] and other Leishmania species [15][16][17] as antigen, and they detected IgG [12,14,15,17,18], IgM [12] or IgA antibodies [13].…”
mentioning
confidence: 99%
“…Two antigens were prepared for each parasite species: one followed a preparation 6 , consisting of an alkaline promastigote extract and another consisting of the same alkaline extract to which 1 ul% of phenylmethane sulphonyl fluoride (PMSF) was added prior to cell disruption 16 .…”
Section: Seramentioning
confidence: 99%
“…Sera were drawn from male patients (86.0%) and female (13.8%), 7 to 83 years of age. On previous assays sera had tested positive for anti-Leishmania IgG class antibodies by a L. major-like enzyme-linked immunoassay ELISA 6 thirteen sera were drawn from in-patients at the Department of Dermatology, University of São Paulo Medical School, and 16 were drawn at regional offices of the Fundação Nacional de Saúde, Brazilian Ministry of Health. Twentytwo sera previously found to be negative for a n t i -L e i s h m a n i a a n t i b o d i e s a n d a n t iTrypanosoma cruzi antibodies by IgGimmunofluorescence 11 and IgG-Elisa, were used as negative controls.…”
mentioning
confidence: 99%